Objective
We’ll try to see positive marks for FXM that it has antibodies against a more abundant protein of the human nerve, PMP2.
We also want to test purified IgG and other positive patients as LAC and JML which are positive for neurofascin (strong positives of a non-abundant protein; different from FXM).
Material
see the last dot_blot
- lysate of human nerve with crosslink buffer
- lysate of human nerve with crosslink buffer and washed with protein A/G
Methods
see the last dot_blot
Changes:
- Put a drop of each lysate in the same membrane
- Sera incubation 1/100 in a wet chamber
- Purified IgG also 1/100 in a wet chamber
Distribution:
- JML_IgG
- FXM_IgG
- JML
- LAC
- Ctrl
- FXM
Results
We cannot see positive marks in any dot.
Conclusions
We’ll change the experiment. Our new approach for the screening is to label purified IgG from patients with fluorescence and then do an IHC with human nerve.